Objectives
Since orodispersible (ODx) and mucoadhesive buccal (MBx) drug formulations have been introduced to the pharmaceutical market these special dosage forms have been continuously evolved both in academia and industry. APV have addressed the topic quite early in the year 2013 and continued with the winter conference 2015 in Innsbruck where a systematic terminology and the abbreviations have been introduced and jointly agreed upon which are nowadays commonly used around the globe by scientists, pharmaceutical companies and even competent authorities. After the last APV winter conference on this topic back in 2016 it is now time to convene again to commonly reflect on advanced technologies, materials, new drug products on the market and future opportunities. An overview of these dosage forms will be followed by presentations from distinguished speakers and thorough discussions on recent advances for both newcomers in this area and experts who will jointly learn and discuss about benefits of new grades of excipients, manufacturing and processes in different settings as well as biopharmaceutical and clinical considerations for ODx & MBx.
The contents are available 12 months after your booking.
Target group
The seminar is highly recommended for pharmacists in community pharmacies, hospital pharmacies or industry, other scientists or engineers operating in pharmaceutical development, manufacturing and business development.
Get your Ticket
Units
Introduction into ODTs and ODMTs
Effect of co-processed excipients on the properties of orodispersible tablets
Templated Inverted Particles (TIP) technology – scientific background and practical potentials
Stability as challenge for orodispersible tablets
Lactose in ODTs – particle engineering for superior mouthfeel
Functional excipients to unlock the potential of ODTs
Impact of lubrication on processing and quality attributes of OD(M)Ts
Acceptability of orodispersible films in neonates and infants
Printing ODFs in a hospital setting – what the hospital pharmacy needs
Data-enriched edible pharmaceuticals (DEEP)
Packaging of film formulations
Carbopol polymers – efficient mucoadhesive excipients for buccal drug formulations
Orodispersible films vehicle for compounding personalized medications
Authors
- Raphael Wiedey, Merck Healthcare, Darmstadt, Germany
- Witold Brniak, University of Krakow, Poland
- Jonas Kost, University of Basel, Switzerland
- Leonhard Ohrem, Merck, Germany
- Daniel Sieber, DFE Pharma, Goch, Germany
- Christian Mühlenfeld, Ashland, Germany
- Jörg Breitkreutz, Heinrich Heine University Düsseldorf, Germany
- Viviane Klingmann, University Children’s Hospital Düsseldorf, Germany
- Torsten Hoppe-Tichy, Pharmacy Department, Heidelberg University Hospital, Germany
- Natalja Genina, University of Copenhagen, Denmark
- Werner Volk, Optima Packaging, Michelfeld, Germany
- Theresa Reimers, IMCD, Cologne, Germany
- Hudson Polonini, Fagron Personalizing Medicine, Rotterdam, The Netherlands